Published in Telemedicine Business Week, August 18th, 2004
"Multiple sclerosis is a major cause of non-traumatic neurological disability," scientists in England explained. "The identification of markers that differentiate disease progression is critical to effective therapy."
In a study conducted by J.L. Griffin and colleagues at the University of Cambridge, a "combination of NMR spectroscopic metabolic profiling of urine and statistical pattern recognition was used to detect focal inflammatory central nervous system (CNS) lesions induced by microinjection of a replication-deficient recombinant adenovirus expressing TNF-alpha or IL1-beta cDNA into...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week